These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9874607)

  • 21. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current possibilities in the therapy and prevention of bone metastases in breast carcinoma?].
    Diel IJ
    Zentralbl Gynakol; 1991; 113(19):1023-4. PubMed ID: 1835815
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
    Elomaa I; Blomqvist C; Porkka L; Lamberg-Allardt C; Borgström GH
    Bone; 1987; 8 Suppl 1():S53-6. PubMed ID: 2961355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates as adjuvant treatment for breast cancer.
    Gralow JR
    BMJ; 2002 Nov; 325(7372):1051-2. PubMed ID: 12424151
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is pamidronate or clodronate better?].
    Adam Z
    Vnitr Lek; 2002 Apr; 48(4):357. PubMed ID: 12075601
    [No Abstract]   [Full Text] [Related]  

  • 26. Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric study.
    Saarto T; Taube T; Blomqvist C; Vehmanen L; Elomaa I
    Calcif Tissue Int; 2005 Aug; 77(2):84-90. PubMed ID: 16075363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of Clodronate in the treatment of bone metastasis].
    Pouillart P; Beuzeboc P
    Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role and use of biphosphonates in the treatment of metastatic breast cancer].
    Caulin F
    Pathol Biol (Paris); 1990 Oct; 38(8):862-3. PubMed ID: 2148817
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer.
    McCloskey E; Paterson A; Kanis J; Tähtelä R; Powles T
    Eur J Cancer; 2010 Feb; 46(3):558-65. PubMed ID: 20031392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clodronate : a review of its use in the prevention of bone metastases and the management of skeletal complications associated with bone metastases in patients with breast cancer.
    Dando TM; Wiseman LR
    Drugs Aging; 2004; 21(14):949-62. PubMed ID: 15554753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.
    Powles T; Paterson S; Kanis JA; McCloskey E; Ashley S; Tidy A; Rosenqvist K; Smith I; Ottestad L; Legault S; Pajunen M; Nevantaus A; Männistö E; Suovuori A; Atula S; Nevalainen J; Pylkkänen L
    J Clin Oncol; 2002 Aug; 20(15):3219-24. PubMed ID: 12149294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral bisphosphonates as adjuvant therapy for operable breast cancer.
    Powles T; McCroskey E; Paterson A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6301s-6304s. PubMed ID: 17062718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimizing breast cancer's spread.
    Health News; 1998 Sep; 4(11):6. PubMed ID: 9745391
    [No Abstract]   [Full Text] [Related]  

  • 35. [An experience with combined therapy of radiation and Bonephos for osteolytic metastases of breast cancer].
    Poliakov PIu; Larionova NA; Bychenkov OA; Moc'kin VG
    Vopr Onkol; 1999; 45(3):311-3. PubMed ID: 10443239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group.
    Mardiak J; Bohunický L; Chovanec J; Sálek T; Koza I
    Neoplasma; 2000; 47(3):177-80. PubMed ID: 11043842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström GH
    Biomed Pharmacother; 1988; 42(2):111-6. PubMed ID: 2971403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aredia: the once-monthly infusion for the treatment of bone metastases.
    Lipton A
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.